Literature DB >> 24889739

Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.

Jackson Orem1, Sven Sandin, Edward Mbidde, Fred Wabwire Mangen, Jaap Middeldorp, Elisabete Weiderpass.   

Abstract

Epstein-Barr virus (EBV) has been linked to malignancies and chronic inflammatory conditions. In this study, EBV detection was compared in children with non-Hodgkin's lymphoma and children with chronic inflammatory conditions, using samples and data from a case-control study carried out at the Mulago National Referral Hospital between 2004 and 2008. EBV viral load was measured in saliva, whole blood and white blood cells by real-time PCR. Serological values for IgG-VCA, EBNA1, and EAd-IgG were compared in non-Hodgkin's lymphoma and chronic inflammatory conditions; and in Burkitt's lymphoma and other subtypes of non-Hodgkin's lymphoma. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated. Of the 127 children included (87 males and 40 females; median age 7 years, range 2-17), 96 had non-Hodgkin's lymphoma (46 Burkitt's lymphoma and 50 other non-Hodgkin's lymphoma), 31 had chronic inflammatory conditions, and only 10% were HIV-positive. The most common clinical presentations for all disease categories considered were fever, night sweats, and weight loss. EBV viral load in whole blood was elevated in Burkitt's lymphoma compared to other non-Hodgkin's lymphoma (OR 6.67, 95% CI 1.32, 33.69; P-value = 0.04), but EBV viral loads in saliva and white blood cells were not different in any of the disease categories considered. A significant difference in EAd-IgG was observed when non-Hodgkin's lymphoma was compared with chronic inflammatory conditions (OR 0.19, 95% CI 0.07, 0.51; P-value = 0.001). When compared to chronic inflammatory conditions, EBV viral load was elevated in Burkitt's lymphoma, and EA IgG was higher in non-Hodgkin's lymphoma. This study supports an association between virological and serological markers of EBV and childhood non-Hodgkin's lymphoma, irrespective of subtype, in Uganda.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Burkitt's lymphoma; Epstein-Barr virus; HIV; children; non-Hodgkin's lymphoma

Mesh:

Substances:

Year:  2014        PMID: 24889739     DOI: 10.1002/jmv.23988

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Childhood cancer: an emerging public health issue in China.

Authors:  Lingeng Lu; Chan Huang; Huatian Huang
Journal:  Ann Transl Med       Date:  2015-10

2.  Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.

Authors:  Katherine D Westmoreland; Nathan D Montgomery; Christopher C Stanley; Nader Kim El-Mallawany; Peter Wasswa; Toon van der Gronde; Idah Mtete; Mercy Butia; Salama Itimu; Mary Chasela; Mary Mtunda; Coxcilly Kampani; N George Liomba; Tamiwe Tomoka; Bal M Dhungel; Marcia K Sanders; Robert Krysiak; Peter Kazembe; Dirk P Dittmer; Yuri Fedoriw; Satish Gopal
Journal:  Int J Cancer       Date:  2017-03-24       Impact factor: 7.396

3.  Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium.

Authors:  Steven A Brown; Salma Abbas; Mary-Ann Davies; Torsak Bunupuradah; Annette H Sohn; Karl-Günter Technau; Lorna Renner; Valériane Leroy; Andrew Edmonds; Marcel Yotebieng; Catherine C McGowan; Stephany N Duda; Lynne Mofenson; Beverly Musick; Kara Wools-Kaloustian
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.731

4.  Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.

Authors:  Sidney Ogolla; Ibrahim I Daud; Amolo S Asito; Odada P Sumba; Collins Ouma; John Vulule; Jaap M Middeldorp; Arlene E Dent; Saurabh Mehta; Rosemary Rochford
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

Review 5.  Cancer Risk Studies and Priority Areas for Cancer Risk Appraisal in Uganda.

Authors:  Alfred Jatho; Binh Thang Tran; Jansen Marcos Cambia; Miisa Nanyingi; Noleb Mugume Mugisha
Journal:  Ann Glob Health       Date:  2020-07-07       Impact factor: 2.462

Review 6.  Emerging role of human polyomaviruses 6 and 7 in human cancers.

Authors:  Ghalib Mobaraki; Dan Liu; Faisal Klufah; Raed A Alharbi; Anna Kordelia Kurz; Ernst Jan M Speel; Véronique Winnepenninckx; Axel Zur Hausen
Journal:  Infect Agent Cancer       Date:  2021-05-17       Impact factor: 2.965

7.  Quantitative cytokine level of TNF-α, IFN-γ, IL-10, TGF-β and circulating Epstein-Barr virus DNA load in individuals with acute Malaria due to P. falciparum or P. vivax or double infection in a Malaria endemic region in Indonesia.

Authors:  Insani Budiningsih; Yoes Prijatna Dachlan; Usman Hadi; Jaap Michiel Middeldorp
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

8.  Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.

Authors:  Samantha Correia; Anne Palser; Claudio Elgueta Karstegl; Jaap M Middeldorp; Octavia Ramayanti; Jeffrey I Cohen; Allan Hildesheim; Maria Dolores Fellner; Joelle Wiels; Robert E White; Paul Kellam; Paul J Farrell
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

9.  High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.

Authors:  Nathan D Montgomery; Cara Randall; Matthew Painschab; Ryan Seguin; Bongani Kaimila; Edwards Kasonkanji; Takondwa Zuze; Robert Krysiak; Marcia K Sanders; Avian Elliott; Melissa B Miller; Coxcilly Kampani; Fred Chimzimu; Maurice Mulenga; Blossom Damania; Tamiwe Tomoka; Yuri Fedoriw; Dirk P Dittmer; Satish Gopal
Journal:  Cancer Med       Date:  2019-11-29       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.